BVT Knock-Out ABT/ DE000VU4KU23 /
5/22/2024 11:43:13 AM | Chg.-0.02 | Bid12:15:50 PM | Ask12:15:50 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.91EUR | -1.04% | 1.90 Bid Size: 23,000 |
1.92 Ask Size: 23,000 |
Abbott Laboratories | 82.22 USD | 12/31/2078 | Call |
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors